Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients
dc.contributor.author | Riquelme, AJ | |
dc.contributor.author | Calvo, MA | |
dc.contributor.author | Guzman, AM | |
dc.contributor.author | Depix, MS | |
dc.contributor.author | Garcia, P | |
dc.contributor.author | Perez, C | |
dc.contributor.author | Arrese, M | |
dc.contributor.author | Labarca, JA | |
dc.date.accessioned | 2024-01-10T12:08:21Z | |
dc.date.available | 2024-01-10T12:08:21Z | |
dc.date.issued | 2003 | |
dc.description.abstract | Saccharomyces boulardii is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii. Molecular typing confirmed clonality in isolate strains from patients and the S. boulardii capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use. | |
dc.fechaingreso.objetodigital | 2024-04-30 | |
dc.format.extent | 3 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1097/00004836-200301000-00013 | |
dc.identifier.eissn | 1539-2031 | |
dc.identifier.issn | 0192-0790 | |
dc.identifier.pubmedid | MEDLINE:12488707 | |
dc.identifier.uri | https://doi.org/10.1097/00004836-200301000-00013 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/76383 | |
dc.identifier.wosid | WOS:000180031600013 | |
dc.information.autoruc | Medicina;Arrese M;S/I;76095 | |
dc.information.autoruc | Medicina;Riquelme A;S/I;3538 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.pagina.final | 43 | |
dc.pagina.inicio | 41 | |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
dc.revista | JOURNAL OF CLINICAL GASTROENTEROLOGY | |
dc.rights | acceso restringido | |
dc.subject | Saccharomyces cerevisiae fungemia | |
dc.subject | Saccharomyces boulardii | |
dc.subject | immunocompromised patients | |
dc.subject | ANTIBIOTIC-ASSOCIATED DIARRHEA | |
dc.subject | IDENTIFICATION | |
dc.subject | PREVENTION | |
dc.subject | CHILDREN | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients | |
dc.type | artículo | |
dc.volumen | 36 | |
sipa.codpersvinculados | 76095 | |
sipa.codpersvinculados | 3538 | |
sipa.index | WOS | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.pdf
- Size:
- 2.37 KB
- Format:
- Adobe Portable Document Format
- Description: